- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06950411
Validation of AI Lumbar Spine Anatomy Measureing Function (Spinal cord)
April 24, 2025 updated by: RadiRad Co., Ltd.
Functionality Assessment of RadiSpine, an Artificial Intelligence Software as Medical Device for Lumbar Spine Quantification System
Spinal degeneration and its associated clinical diseases are common ailments in aging societies.
With the advent of a super-aging society, the importance of assistive technologies for spinal image interpretation is increasingly significant to enhance care efficiency and reduce medical personnel expenditure.
Recently, due to the rapid development of artificial intelligence (AI) algorithm, AI-based computer-assisted detection (CADe) devices gradiually become a convenient method for spinal anatomy measurement.
However, the accuracy of these devices has not been fully established.
This study aims to validate the performance of RadiSpine (an application program) in spinal anatomy segmentation and measurement.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 112
- Taipei Veterans General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
The subjects should be aged 20 or older and younger than 75, with an equal gender distribution of 50% male and 50% female.
From this group, 150 subjects with reasonable datavalues will be selected, with a requirement that at least 30% of them are male and at least 30% are female.
Description
Inclusion Criteria:
The subjects should be aged 20 or older and younger than 75, with an equal gender distribution of 50% male and 50% female. From this group, 150 subjects with reasonable datavalues will be selected, with a requirement that at least 30% of them are male and at least 30% are female.
Exclusion Criteria:
- With history of spinal surgery
- Spinal trauma
- Spinal osteoporosis
- Spinal metastasis or infection
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Segmentation accuracy (Mean)
Time Frame: 30 mins per individual
|
The minimum Mean Dice Coefficient (MDC), defined as the lower limit of the 95% confidence interval (CI) for MDC, is above a predetermined allowable limit equal to 0.8
|
30 mins per individual
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Measurement accuracy
Time Frame: 30 mins per individual
|
The maximum Mean Absolute Error (MAE), defined as the upper limit of the 95% CI for MAE, is below a predetermined allowable error limit equal to 2 mm
|
30 mins per individual
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
September 12, 2024
Primary Completion (Actual)
March 31, 2025
Study Completion (Actual)
March 31, 2025
Study Registration Dates
First Submitted
April 10, 2025
First Submitted That Met QC Criteria
April 24, 2025
First Posted (Actual)
April 30, 2025
Study Record Updates
Last Update Posted (Actual)
April 30, 2025
Last Update Submitted That Met QC Criteria
April 24, 2025
Last Verified
April 1, 2025
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- Validation of Spinal Anatomy
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spinal Cord Compression
-
University of MiamiViewray Inc.Not yet recruitingSpinal Cord Compression | Metastatic Epidural Spinal Cord CompressionUnited States
-
The Christie NHS Foundation TrustRecruitingMetastatic Spinal Cord CompressionUnited Kingdom
-
M.D. Anderson Cancer CenterActive, not recruitingMetastatic Epidural Spinal Cord CompressionUnited States
-
Washington University School of MedicineCelgeneTerminatedCord CompressionUnited States
-
M.D. Anderson Cancer CenterCompletedMetastatic Epidural Spinal Cord CompressionUnited States
-
The University of Texas Health Science Center,...TerminatedSpinal Cord Injuries | Cervical Spinal Cord Injury | Traumatic Spinal Cord CompressionUnited States
-
Peking University Third HospitalNot yet recruitingMalignant Spinal Cord Compression
-
University Hospital Schleswig-HolsteinTerminatedSpinal Cord Compression Due to Metastasis to SpineGermany
-
University Hospital Schleswig-HolsteinCompletedSpinal Cord Compression Due to Metastasis to SpineGermany
-
Prof. Dirk Rades, MDCompletedMetastatic Epidural Spinal Cord CompressionUnited States, Slovenia, Germany, Lithuania, Saudi Arabia, Spain